Firmus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 5.56 M
as on 15-11-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.75 Cr
as on 15-11-2024
- Satisfied Charges ₹ 10.76 Cr
as on 15-11-2024
- Revenue 72.02%
(FY 2023)
- Profit -30.74%
(FY 2023)
- Ebitda 5.37%
(FY 2023)
- Net Worth 6.83%
(FY 2023)
- Total Assets 63.48%
(FY 2023)
About Firmus Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 5.56 M.
The company currently has active open charges totaling ₹6.75 Cr. The company has closed loans amounting to ₹10.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hari Chennamadhauni, Madhavi Chennamadhauni, Rajendra Byreddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2014PTC096246
- Company No.
096246
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Firmus Laboratories Private Limited offer?
Firmus Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Flavours & Aromatics, Food Flavour, API (Active Pharmaceutical Ingredients), Theobromine Powder API, Organic Chemicals, Methyl Phenyl Acetic Acid, Glutaric Acid.
Who are the key members and board of directors at Firmus Laboratories?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hari Chennamadhauni | Director | 11-Jul-2015 | Current |
Madhavi Chennamadhauni | Director | 11-Jul-2015 | Current |
Rajendra Byreddy | Director | 07-Sep-2015 | Current |
Siva Thunuguntla | Director | 21-Jan-2016 | Current |
Padmini Thunuguntla | Director | 07-Sep-2015 | Current |
Financial Performance and Corporate Structure Insights of Firmus Laboratories.
Firmus Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.02% increase. The company also saw a substantial fall in profitability, with a 30.74% decrease in profit. The company's net worth moved up by a moderate rise of 6.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Firmus Laboratories?
In 2023, Firmus Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Salubrious Laboratories Private LimitedActive 24 years 29 days
Hari Chennamadhauni and Madhavi Chennamadhauni are mutual person
- Cmh Laboratories Private LimitedActive 1 year 11 months
Hari Chennamadhauni and Madhavi Chennamadhauni are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 14 Aug 2023 | ₹6.00 M | Open |
Others Creation Date: 12 Jul 2022 | ₹6.15 Cr | Open |
Others Creation Date: 27 Feb 2020 | ₹4.93 Cr | Satisfied |
How Many Employees Work at Firmus Laboratories?
Firmus Laboratories has a workforce of 33 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Firmus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Firmus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.